Emerald Advisers’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-171,023
| Closed | -$24.9M | – | 264 |
|
|
2022
Q2 | $24.9M | Sell |
171,023
-145,363
| -46% | -$21.2M | 1.28% | 23 |
|
|
2022
Q1 | $37.5M | Buy |
316,386
+59,686
| +23% | +$7.08M | 1.43% | 16 |
|
|
2021
Q4 | $35.4M | Buy |
256,700
+49,694
| +24% | +$6.85M | 1.31% | 23 |
|
|
2021
Q3 | $28.8M | Buy |
+207,006
| New | +$28.8M | 1.04% | 31 |
|
|
2021
Q1 | – | Sell |
-81,616
| Closed | -$7M | – | 318 |
|
|
2020
Q4 | $7M | Sell |
81,616
-116,836
| -59% | -$10M | 0.23% | 115 |
|
|
2020
Q3 | $12.9M | Sell |
198,452
-297,267
| -60% | -$19.3M | 0.53% | 74 |
|
|
2020
Q2 | $36.2M | Sell |
495,719
-84,960
| -15% | -$6.21M | 1.58% | 10 |
|
|
2020
Q1 | $19.8M | Buy |
580,679
+99,185
| +21% | +$3.38M | 1.14% | 27 |
|
|
2019
Q4 | $26.2M | Buy |
481,494
+164,848
| +52% | +$8.97M | 1.11% | 26 |
|
|
2019
Q3 | $13.2M | Sell |
316,646
-21,004
| -6% | -$876K | 0.62% | 64 |
|
|
2019
Q2 | $14.8M | Sell |
337,650
-255,143
| -43% | -$11.2M | 0.59% | 72 |
|
|
2019
Q1 | $30.5M | Buy |
592,793
+22,625
| +4% | +$1.16M | 1.24% | 23 |
|
|
2018
Q4 | $21.1M | Sell |
570,168
-10,245
| -2% | -$379K | 1.04% | 35 |
|
|
2018
Q3 | $21.8M | Buy |
580,413
+175,049
| +43% | +$6.57M | 0.8% | 44 |
|
|
2018
Q2 | $16M | Buy |
405,364
+42,115
| +12% | +$1.66M | 0.6% | 82 |
|
|
2018
Q1 | $9.36M | Sell |
363,249
-6,533
| -2% | -$168K | 0.38% | 106 |
|
|
2017
Q4 | $9.98M | Buy |
369,782
+126,455
| +52% | +$3.41M | 0.38% | 102 |
|
|
2017
Q3 | $9.1M | Sell |
243,327
-254,553
| -51% | -$9.52M | 0.37% | 101 |
|
|
2017
Q2 | $12.4M | Buy |
+497,880
| New | +$12.4M | 0.52% | 79 |
|